- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
Chugai Pharmaceutical
Market Cap: JP¥12.4t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,554.00
7D
0.4%
1Y
59.1%
Daiichi Sankyo Company
Market Cap: JP¥7.0t
Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.
4568
JP¥3,741.00
7D
8.3%
1Y
-31.3%
Orion Oyj
Market Cap: €8.3b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€58.90
7D
5.3%
1Y
56.6%
Imeik Technology DevelopmentLtd
Market Cap: CN¥52.1b
Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.
300896
CN¥171.65
7D
-0.2%
1Y
-18.6%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥39.3b
Shanghai Allist Pharmaceuticals Co., Ltd.
688578
CN¥86.29
7D
2.3%
1Y
51.8%
Xiamen Amoytop Biotech
Market Cap: CN¥28.9b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥74.58
7D
2.1%
1Y
36.6%
Laboratorios Farmaceuticos Rovi
Market Cap: €2.6b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€51.80
7D
-1.1%
1Y
-42.5%